Evaluation of medicines 2020

The Rendu Medical Service and the Improvement of the Rendu Medical Service are concepts allowing the High Health Authority (HAS) to propose the inclusion of a drug on the list of reimbursable specialties in the city and/or hospital. Therefore, only medicinal products for which the marketing laboratory wishes to be included in this list will be subject to an evaluation of the MRS and the ASMR. Furthermore, generic drugs are not systematically evaluated for MRS and ASMR. Only the most recent evaluations are presented. Previous evaluations remain available in the form of textual notices on the HAS website (https://www.has-sante.fr/portail/jcms/r_1500918/fr/les-avis-sur-les-medicaments) or upon request from its services.